Cervical Ca PROs in Clinical Practice
Palabras clave
Abstracto
fechas
Verificado por última vez: | 03/31/2019 |
Primero enviado: | 02/06/2017 |
Inscripción estimada enviada: | 02/06/2017 |
Publicado por primera vez: | 02/08/2017 |
Última actualización enviada: | 04/23/2019 |
Última actualización publicada: | 04/24/2019 |
Fecha de inicio real del estudio: | 02/26/2017 |
Fecha estimada de finalización primaria: | 10/31/2020 |
Fecha estimada de finalización del estudio: | 10/31/2020 |
Condición o enfermedad
Intervención / tratamiento
Other: Cervical Cancer Patients
Other: Oncologist
Fase
Grupos de brazos
Brazo | Intervención / tratamiento |
---|---|
Cervical Cancer Patients Adult, English-speaking cervical cancer patients, who have been treated with curative intent chemo-radiotherapy. | Other: Cervical Cancer Patients Disease specific Patient Reported Outcome measurement tool developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire covers symptoms common to women with cervical cancer and captures the impact of disease and/or treatment on domains including: urologic and gastro-intestinal symptoms, sexual functioning and body image. |
Oncologist Oncologists who treat cervix cancer, with at least one consenting patient enrolled in the study. | Other: Oncologist This Feedback form to be completed by oncologists who have had at least one consenting patient participating in this study. |
Criterio de elegibilidad
Edades elegibles para estudiar | 18 Years A 18 Years |
Sexos elegibles para estudiar | All |
Método de muestreo | Non-Probability Sample |
Acepta voluntarios saludables | si |
Criterios | Patient Inclusion Criteria: 1. Adult (> 18 years) English speaking patients 2. Treated with curative intent with chemo-radiotherapy 3. Seen in routine clinic follow-up within 5 years post completion of treatment Patient Exclusion Criteria: 1. Patients at their anticipated last clinic visit prior to cancer center discharge 2. Patients unable to complete the EORTC QLQ CX-24 questionnaire due to inability to read or write. 3. Non-English speaking patients 4. Patients of the principal investigator. The rationale for this is that patients of the principal investigator who complete the Feedback form may be biased and this may be reflected in the results. Oncologist Inclusion Criteria: 1. Oncologists who treat cervix cancer 2. Oncologists with at least one consenting patient enrolled in the study Oncologist Exclusion Criteria: 1) Principal investigator listed on the protocol. The rationale for this is that oncologists who are also investigators on this study may have inherent bias in the study which may be reflected in the results of the Feedback form. |
Salir
Medidas de resultado primarias
1. Percentage of EORTC QLQ CX24 questionnaire completed [9 months]
2. Percentage of favorable scores (Agree or strongly agree) on Feedback Form [9 months]